Dr Erica Stewart, Centenary Institute[/caption]
Chelsea Felkai, MPS[/caption]
Working with the nursing staff to understand when PRN (as required) chemical restraint might be used, and ensuring other options have been exhausted first, has shown the most reduction in how much psychotropic medications have been used so far. The numbers are relatively small, but to be honest, this is largely because the facility had great protocols to begin with.
Dr Natalie Soulsby FPS[/caption]
Associate Professor Luke Grzeskowiak[/caption]
Excellence awards for standout pharmacists
The first Aboriginal registered pharmacist, a hard-working mother and two industry pioneers were recognised with excellence awards at PSA22.
‘Don’t be ambiguous’ on complementary medicines
New research from the University of Queensland will help pharmacists to provide evidence-based advice to consumers purchasing supplements and complementary medicines.
What pharmacists learnt in 2021
The last year has been one of the most challenging to date. But as these stories highlight, pharmacists have continued to improve the lives of Australians throughout the pandemic.
Pharmacists and Charcot-Marie-Tooth disease
Charcot–Marie–Tooth disease (CMT) is the most commonly inherited neuromuscular disorder, affecting almost 10,000 Australians.
Help is at hand to understand electronic prescribing
From dispensing using a digital image to the fast-tracking of electronic prescriptions, Australian pharmacists have been at the forefront of digital transformation during the COVID-19 pandemic.
Active ingredient prescribing arrives
With active ingredient prescribing coming into effect next month, Australian Pharmacist looks at how to prepare your practice and patients for the change.
